Stanford Moyamoya Picnic
Join us Saturday, June 14, 2008 at Mitchell Park in Palo Alto. Read more information.

Moyamoya Newsletter
Read the current edition of the Moyamoya Newsletter.

Neurosciences
Neurosurgery and Neurology strive to improve diagnostic and treatment methods for neurological diseases.

HOME > Clinical Services > Neurosciences > Moyamoya Disease

Email Print
The Moyamoya Center

What is Moyamoya?

Moyamoya disease is a progressive disorder that affects the blood supply to the brain. It is rare, but is being detected more frequently with recent advances in diagnostic imaging. 

It can occur at any time, but is most commonly diagnosed in childhood between ages 5 - 15 and during adulthood between ages 30 - 40. 

History of Moyamoya

Moyamoya was first identified by the Japanese, who named it for the appearance of a “puff of smoke” that appeared on the cerebral angiogram. It is more common in Asians, but can affect any population.

 

Moyamoya disease is characterized by a progressive narrowing of the internal carotid arteries leading into the brain, and usually affects both sides of the brain.

The cause of arterial narrowing is unknown, but does not appear related to atherosclerosis or inflammation of the arteries.  

As the vessels narrow the brain receives less blood. This can result in temporary symptoms such as:

  • Headaches
  • Numbness or weakness in the extremities
  • Difficulty speaking
  • Stroke

Dr. Steinberg with Stanford Moyamoya patient.             

Dr. Steinberg with Stanford Moyamoya patient.

Dr. Steinberg with Moyamoya patient    
1993

Dr. Steinberg with the same Moyamoya
patient 2004


Symptoms

Children typically have symptoms including:

  • Strokes (sustained weakness or numbness in an arm or leg, difficulty speaking, visual abnormalities or problems walking)
  • Transient ischemic attacks, or TIA’s (temporary stroke-like symptoms that don’t last long)
  • Headaches
  • Progressive cognitive or learning impairments

Children also often experience temporary weakness in one or more of their extremities during strenuous physical activity or when crying. Adults can also present with brain hemorrhage causing neurologic symptoms in addition to nonhemorrhagic strokes, TIA’s and headaches.

 

Moyamoya sometimes occurs along with other disorders such as Down’s Syndrome, brain AVM’s (arteriovenous malformations), and neurofibromatosis. We have also seen it in patients who had previous brain radiation for tumors.

Diagnosis

Based on the patients’ symptoms and history, the physician may order one or all of these tests before making a decision about treatment.

Magnetic Resonance Imaging (MRI)
This allows physicians to examine brain structures and detect any strokes that might have occurred. 

Moyamoya MRI with large stroke from Moyamoya MRI. The arrows on this MRI of the brain shows a patient with a large stroke from moyamoya.

 


Cerebral Angiogram

This is the definitive test that confirms the diagnosis of moyamoya. “Contrast” (or dye) is injected into arteries to reveal the anatomy of the arteries of the brain and scalp. This is a minimally invasive test that requires patients to stay at the hospital for several hours. This test assesses the severity of moyamoya and its results guide treatment options, which are determined by how severe the disease is and what the external (scalp) blood supply is. 

 
Slide view of a normal angiogram.

MCA=middle cerebral artery
ACA=anterior cerebral artery
ICA=internal carotid artery
Angiogram of a patient with moyamoya disease. You can see the MCA and ACA vessels are imparied and moyamoya vessels have appeared along with other collateral vessels.



Xenon CT Scans

This test reveals blood flow to regions of the brain to determine if enough blood is reaching all areas. Patients breathe xenon (an odorless, colorless gas), which acts as a contrast agent to show regions of low and high blood flow.

Pre-Operative             Post Operative

Pre-Diamox







Post-Diamox

Note the areas of red, which indicate a higher volume of blood flow to the brain when challenged with Diamox.

Resources
Clinical Trials & Research
Moyamoya Disease

Stanford School of Medicine, Department of Neurosurgery
[TOP]  
Stanford Hospital & Clinics   300 Pasteur Drive   Stanford, California 94305   (650) 723-4000
Legal Notices and Disclaimer   Copyright 2001-2008 Stanford Hospital & Clinics. All rights reserved.